XJPX3540
Market cap53mUSD
Jan 14, Last price
849.00JPY
1D
-2.41%
1Q
-33.88%
IPO
-58.59%
Name
CI Medical Co Ltd
Chart & Performance
P/E
4.08
P/S
0.19
EPS
208.20
Div Yield, %
2.97%
Shrs. gr., 5y
—
Rev. gr., 5y
9.65%
Revenues
45.63b
+6.38%
Net income
2.08b
-17.41%
CFO
-156m
L
Dividend
Dec 28, 202325.22 JPY/sh
Profile
C.I. Medical Co.,Ltd. designs, manufactures, and sells dental care products in Japan. The company offers tooth brushes; and other dental care products through mail order sales. It also provides milling machines, scanners, and software solutions to dental facilities, as well as deals in dental clinical products, including high-tech dental machines. The company serves medical cooperatives, dental clinics, dental associations, health centers, dental colleges, hospitals, veterinary clinics, nursing and care facilities, and dental dealers. C.I. Medical Co.,Ltd. was incorporated in 2000 and is headquartered in Hakusan, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 45,628,000 6.38% | 42,891,000 4.09% | |||
Cost of revenue | 42,664,000 | 38,913,000 | |||
Unusual Expense (Income) | |||||
NOPBT | 2,964,000 | 3,978,000 | |||
NOPBT Margin | 6.50% | 9.27% | |||
Operating Taxes | 1,084,000 | 1,326,000 | |||
Tax Rate | 36.57% | 33.33% | |||
NOPAT | 1,880,000 | 2,652,000 | |||
Net income | 2,082,000 -17.41% | 2,521,000 -10.60% | |||
Dividends | (252,000) | (282,000) | |||
Dividend yield | 0.12% | 0.11% | |||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | 17,129,000 | 7,027,000 | |||
Long-term debt | 64,000 | 65,000 | |||
Deferred revenue | |||||
Other long-term liabilities | 434,000 | 425,000 | |||
Net debt | 14,354,000 | 5,175,000 | |||
| Cash flow | |||||
Cash from operating activities | (156,000) | 1,409,000 | |||
CAPEX | (8,930,000) | (9,348,000) | |||
Cash from investing activities | (9,795,000) | (10,049,000) | |||
Cash from financing activities | 9,825,000 | 6,710,000 | |||
FCF | (9,586,000) | (7,636,000) | |||
| Balance | |||||
Cash | 1,804,000 | 1,826,000 | |||
Long term investments | 1,035,000 | 91,000 | |||
Excess cash | 557,600 | ||||
Stockholders' equity | 20,169,000 | 18,322,000 | |||
Invested Capital | 37,208,400 | 25,132,000 | |||
ROIC | 6.03% | 13.51% | |||
ROCE | 7.85% | 15.83% | |||
| EV | |||||
Common stock shares outstanding | 49,995 | 49,999 | |||
Price | 4,200.00 -17.00% | 5,060.00 9.17% | |||
Market cap | 209,979,000 -17.00% | 252,997,242 9.17% | |||
EV | 224,413,000 | 258,278,242 | |||
EBITDA | 3,986,000 | 4,374,000 | |||
EV/EBITDA | 56.30 | 59.05 | |||
Interest | 17,000 | 6,000 | |||
Interest/NOPBT | 0.57% | 0.15% | |||